Interleukin-1 and related pro-inflammatory cytokines in the treatment of bacterial infections in neutropenic and non-neutropenic animals.
Bacterial infections in the immunocompromized host cause considerable mortality, and even the recently developed antimicrobial strategies often fail to cure these infections, especially in granulocytopenic patients. Cytokines and hematopoietic growth factors have been shown to stimulate host defense mechanisms in vitro and in vivo. We discuss the possible role of the pro-inflammatory cytokines interleukin-1, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 as modulators of host resistance to bacterial infections. Interleukin-1 has been shown effective in various animal models of potentially lethal bacterial infection, even during severe granulocytopenia. The protective mechanism of interleukin-1 may be mediated via downregulation of cytokine receptors and cytokine production, and via induction of acute phase proteins. Moreover, in subacute and chronic infections interleukin-1 interferes with microbial outgrowth, via mechanisms that have only been partially elucidated.
van der Meer
J W
JW
Department of Medicine, University Hospital Nijmegen, The Netherlands.
Vogels
M T
MT
Kullberg
B J
BJ
D000818:Animals; D001424:Bacterial Infections / Q000097:blood / Q000188:drug therapy* / Q000276:immunology*; D016207:Cytokines / Q000627:therapeutic use*; D006801:Humans; D016867:Immunocompromised Host; D007375:Interleukin-1 / Q000627:therapeutic use*; D009503:Neutropenia / Q000188:drug therapy* / Q000276:immunology*
D016207:Cytokines; D007375:Interleukin-1